Correlation Between Oxford Nanopore and Pharming Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oxford Nanopore and Pharming Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oxford Nanopore and Pharming Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oxford Nanopore Technologies and Pharming Group NV, you can compare the effects of market volatilities on Oxford Nanopore and Pharming Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oxford Nanopore with a short position of Pharming Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oxford Nanopore and Pharming Group.

Diversification Opportunities for Oxford Nanopore and Pharming Group

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Oxford and Pharming is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Oxford Nanopore Technologies and Pharming Group NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharming Group NV and Oxford Nanopore is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oxford Nanopore Technologies are associated (or correlated) with Pharming Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharming Group NV has no effect on the direction of Oxford Nanopore i.e., Oxford Nanopore and Pharming Group go up and down completely randomly.

Pair Corralation between Oxford Nanopore and Pharming Group

Assuming the 90 days horizon Oxford Nanopore Technologies is expected to generate 2.01 times more return on investment than Pharming Group. However, Oxford Nanopore is 2.01 times more volatile than Pharming Group NV. It trades about 0.06 of its potential returns per unit of risk. Pharming Group NV is currently generating about -0.02 per unit of risk. If you would invest  135.00  in Oxford Nanopore Technologies on September 24, 2024 and sell it today you would earn a total of  49.00  from holding Oxford Nanopore Technologies or generate 36.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Oxford Nanopore Technologies  vs.  Pharming Group NV

 Performance 
       Timeline  
Oxford Nanopore Tech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oxford Nanopore Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Oxford Nanopore is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Pharming Group NV 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pharming Group NV are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Pharming Group may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Oxford Nanopore and Pharming Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oxford Nanopore and Pharming Group

The main advantage of trading using opposite Oxford Nanopore and Pharming Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oxford Nanopore position performs unexpectedly, Pharming Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharming Group will offset losses from the drop in Pharming Group's long position.
The idea behind Oxford Nanopore Technologies and Pharming Group NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities